retatrutide type 2 diabetes trial results 2024 phase 2 The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus With Sustained Type 2 Diabetes

Fatigue and Dizziness General weakness, dizziness, and loss of energy are frequently reported, particularly during early dose titration

This is not a technicality or a fine-print detail

Serious adverse events were reported more in the semaglutide group than in the placebo group

So they might also directly impact some of the hormones that regulate your reproductive system, as well as how your ovaries work and, potentially, the lining of your uterus (which sheds when you have your period)

In the scientific literature, it is described as a triple agonist of the GLP-1, GIP and glucagon receptors (GCGR)

However, each medication is intended for use over an extended period, as obesity is recognized as a chronic condition